Similar articles for PMID: 29674423

Year	Number of Results
2006	1
2007	3
2008	1
2011	1
2012	1
2013	8
2014	8
2015	12
2016	14
2017	18
2018	23
2019	2
2020	3
2021	2
2024	0

1

Now Is the Time to Use ¹⁸F-FDG PET/CT to Optimize Neoadjuvant Treatment in Triple-Negative Breast Cancer!

Groheux D. Groheux D. J Nucl Med. 2018 Jun;59(6):863-864. doi: 10.2967/jnumed.118.210922. Epub 2018 Apr 19. J Nucl Med. 2018. PMID: 29674423 Free article. No abstract available.

2

Complete Metabolic Response on Interim ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography to Predict Long-Term Survival in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy.

Chen S, Ibrahim NK, Yan Y, Wong ST, Wang H, Wong FC. Chen S, et al. Oncologist. 2017 May;22(5):526-534. doi: 10.1634/theoncologist.2016-0334. Epub 2017 Apr 4. Oncologist. 2017. PMID: 28377466 Free PMC article.

3

Additional value of ¹⁸F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer.

van Ramshorst MS, Teixeira SC, Koolen BB, Pengel KE, Gilhuijs KG, Wesseling J, Rodenhuis S, Valdés Olmos RA, Rutgers EJ, Vogel WV, Sonke GS, Vrancken Peeters MT. van Ramshorst MS, et al. Cancer Imaging. 2017 May 25;17(1):15. doi: 10.1186/s40644-017-0117-5. Cancer Imaging. 2017. PMID: 28545563 Free PMC article.

4

Role of ¹⁸F-PET/CT in Predicting Prognosis of Patients With Breast Cancer After Neoadjuvant Chemotherapy.

Akimoto E, Kadoya T, Kajitani K, Emi A, Shigematsu H, Ohara M, Masumoto N, Okada M. Akimoto E, et al. Clin Breast Cancer. 2018 Feb;18(1):45-52. doi: 10.1016/j.clbc.2017.09.006. Epub 2017 Sep 19. Clin Breast Cancer. 2018. PMID: 28993056

5

Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancer.

Groheux D, Biard L, Lehmann-Che J, Teixeira L, Bouhidel FA, Poirot B, Bertheau P, Merlet P, Espié M, Resche-Rigon M, Sotiriou C, de Cremoux P. Groheux D, et al. Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1279-1288. doi: 10.1007/s00259-018-3998-z. Epub 2018 Apr 4. Eur J Nucl Med Mol Imaging. 2018. PMID: 29616304

6

Early assessment with 18F-fluorodeoxyglucose positron emission tomography/computed tomography can help predict the outcome of neoadjuvant chemotherapy in triple negative breast cancer.

Groheux D, Hindié E, Giacchetti S, Hamy AS, Berger F, Merlet P, de Roquancourt A, de Cremoux P, Marty M, Hatt M, Espié M. Groheux D, et al. Eur J Cancer. 2014 Jul;50(11):1864-71. doi: 10.1016/j.ejca.2014.04.020. Epub 2014 May 16. Eur J Cancer. 2014. PMID: 24841218

7

18F-FDG PET-Derived Tumor Blood Flow Changes After 1 Cycle of Neoadjuvant Chemotherapy Predicts Outcome in Triple-Negative Breast Cancer.

Humbert O, Riedinger JM, Vrigneaud JM, Kanoun S, Dygai-Cochet I, Berriolo-Riedinger A, Toubeau M, Depardon E, Lassere M, Tisserand S, Fumoleau P, Brunotte F, Cochet A. Humbert O, et al. J Nucl Med. 2016 Nov;57(11):1707-1712. doi: 10.2967/jnumed.116.172759. Epub 2016 Apr 21. J Nucl Med. 2016. PMID: 27103025 Free article. Clinical Trial.

8

(18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer.

Ulaner GA, Castillo R, Goldman DA, Wills J, Riedl CC, Pinker-Domenig K, Jochelson MS, Gönen M. Ulaner GA, et al. Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):1937-44. doi: 10.1007/s00259-016-3402-9. Epub 2016 Apr 30. Eur J Nucl Med Mol Imaging. 2016. PMID: 27129866 Free PMC article.

9

Prediction of breast cancer recurrence using lymph node metabolic and volumetric parameters from ¹⁸F-FDG PET/CT in operable triple-negative breast cancer.

Kim YI, Kim YJ, Paeng JC, Cheon GJ, Lee DS, Chung JK, Kang KW. Kim YI, et al. Eur J Nucl Med Mol Imaging. 2017 Oct;44(11):1787-1795. doi: 10.1007/s00259-017-3748-7. Epub 2017 Jun 14. Eur J Nucl Med Mol Imaging. 2017. PMID: 28616695

10

A rare case of clear cell carcinoma of the breast evaluated by (18)F-FDG PET/CT.

Treglia G, Perriard U, Ceriani L, Giovanella L. Treglia G, et al. Rev Esp Med Nucl Imagen Mol. 2015 Jul-Aug;34(4):264-5. doi: 10.1016/j.remn.2014.11.003. Epub 2015 Jan 5. Rev Esp Med Nucl Imagen Mol. 2015. PMID: 25573809 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

86 results

Results by year